Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,809 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Synergism of a novel MCL‑1 downregulator, acriflavine, with navitoclax (ABT‑263) in triple‑negative breast cancer, lung adenocarcinoma and glioblastoma multiforme.
Lee A, Jin HO, Masudul Haque M, Kim HY, Jung H, Park JH, Kim I, Song JY, Yoon HK, Kim HK, Han J, Park IC, Kim KS, Park SG. Lee A, et al. Among authors: kim hy, kim hk, kim ks, kim i. Int J Oncol. 2022 Jan;60(1):2. doi: 10.3892/ijo.2021.5292. Epub 2021 Dec 16. Int J Oncol. 2022. PMID: 34913076 Free PMC article.
Combined treatment with anti-HER2/neu and anti-4-1BB monoclonal antibodies induces a synergistic antitumor effect but requires dose optimization to maintain immune memory for protection from lethal rechallenge.
Kim HY, Choi JH, Haque MM, Park JH, Kim IH, Choi BK, Lee A, Park S. Kim HY, et al. Among authors: kim ih. Cancer Immunol Immunother. 2022 Apr;71(4):967-978. doi: 10.1007/s00262-021-03120-1. Epub 2022 Jan 6. Cancer Immunol Immunother. 2022. PMID: 34988585 Free PMC article.
6,809 results